{"entity":{"id":"hpv-gender-neutral-programmes","kind":"term","name":"HPV vaccination of boys as well as girls, by country","aka":["gender-neutral HPV vaccination","HPV vaccination for boys"],"tldr":"Of 175 countries and territories reporting a routine HPV schedule to WHO, 94 include boys as well as girls.","summary":"In WHO's schedule table (resource MT_AD_SCHEDULER), read on 4 November 2026 with each country's latest reported year, 94 of the 175 countries and territories with a routine HPV schedule list a target population that includes males. Among the national records here, Brazil, Mexico, France, Italy, Spain, the Netherlands and Switzerland vaccinate girls and boys; Nigeria, Indonesia, Bangladesh, Ethiopia, South Africa and South Korea vaccinate girls only. HPV vaccines are licensed in males against anal cancer and other HPV-related disease as well as in females against cervical cancer (see the gardasil-9 and cervavac records).","asOf":"2026-11-04","links":[{"label":"WHO immunization data: HPV vaccination schedules","url":"https://immunizationdata.who.int/global/wiise-detail-page/vaccination-schedule-for-human-papilloma-virus"}],"tags":["vaccination-programme"],"related":["gardasil-9","cervavac","hpv-programme-france","hpv-programme-italy","hpv-programme-netherlands","hpv-programme-switzerland","hpv-programme-brazil","hpv-programme-mexico","who-immunization-data"],"cancers":["cervical","anal","head-and-neck"],"sections":["prevention"],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":["oncogenic-viruses"],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Epidemiology & prevention"},"route":"/terms/hpv-gender-neutral-programmes/","neighbours":{"drug":[{"id":"cervavac","kind":"drug","name":"CERVAVAC (quadrivalent HPV vaccine, India)","route":"/drugs/cervavac/"},{"id":"gardasil-9","kind":"drug","name":"Nonavalent HPV vaccine","route":"/drugs/gardasil-9/"}],"term":[{"id":"hpv-programme-brazil","kind":"term","name":"HPV vaccination programme in Brazil","route":"/terms/hpv-programme-brazil/"},{"id":"hpv-programme-france","kind":"term","name":"HPV vaccination programme in France","route":"/terms/hpv-programme-france/"},{"id":"hpv-programme-italy","kind":"term","name":"HPV vaccination programme in Italy","route":"/terms/hpv-programme-italy/"},{"id":"hpv-programme-mexico","kind":"term","name":"HPV vaccination programme in Mexico","route":"/terms/hpv-programme-mexico/"},{"id":"hpv-programme-switzerland","kind":"term","name":"HPV vaccination programme in Switzerland","route":"/terms/hpv-programme-switzerland/"},{"id":"hpv-programme-netherlands","kind":"term","name":"HPV vaccination programme in The Netherlands","route":"/terms/hpv-programme-netherlands/"}],"collection":[{"id":"who-immunization-data","kind":"collection","name":"WHO immunization data portal (WIISE)","route":"/collections/who-immunization-data/"}],"cancer":[{"id":"anal","kind":"cancer","name":"Anal cancer (squamous cell carcinoma)","route":"/cancers/anal/"},{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"}],"section":[{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"pathway":[{"id":"oncogenic-viruses","kind":"pathway","name":"Oncogenic viruses","route":"/pathways/oncogenic-viruses/"}]}}